BSEResult6d ago · 12 Aug 2026, 06:13 pm
Unaudited Financial Results for the quarter ended June 30, 2026
Kronox Lab Sciences Ltd · 544187
✦ AI SummaryResults
Kronox Lab Sciences Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue from operations at Rs. 28.13 crores, total income at Rs. 30.64 crores, and profit before tax at Rs. 2.53 crores. The company has also appointed M/s. Diwanji & Associates as its cost auditors for the year 2026-27.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Kronox Lab Sciences Ltd - 544187 - Standalone Unaudited Financail Results For The Quarter Ended June, 2026
Attachments (1)
📄pdf
Download →
03380acb-e15e-46b3-9b74-8ccb58720e10.pdf
View document text
Date: 12" August, 2026
National Stock Exchange of India BSE Limited
Limited
25" Floor,
Exchange Plaza, C-1Block G, Phiroze Jeejeebhoy Towers,
Bandra Kurla Complex
Dalal Street, Fort,
Bandra [E], Mumb- 4a000i51 Mumb-a 4i00 001
NSE Scrip Symbol: KRONOX BSE Scrip Code: 544187
Subject: Outcome of Meeting of Board of Directors
Dear Sir/Madam,
We would like to informyou that pursuantto Regulation 30, Regulation 33 as well as other
Rap ep ql ui ic ra eb ml ee
tsre )g u Rl ea gt ui lo an ts i,
nsif
2a 0ny 1,
(o ‘f
ODt Rh ?’e
S tE hB eI
o( aL ri dst oin fg
iO rb el ci tg oa rt si oo fn s
hea Cnd
mpD ais nc yl o as tu ir te
meeting held on Wednesday, August 12, 2026, inter alia, to consider and approve:
1. The Unaudited Standalone Financial Results for the quarter ended June 30, 2025. A
c eno cp ly
so ef
d .u ly signed audited financial results along with Limited Review Report is
2. Convening of 17" Annual General Meeting (AGM) of the Company on Wednesday,
Septembe16r, 2026.
3. wP iu tr hs u Ra un lt et o
t (h 1e
p or fo Cvi os mi po ans
sSe c (t Mi ao nn
9 g1
t nh te aC no dm p Aa dmn ii ne is
A rc at t,
o2 n0 )1 3 R,
( l‘ et she 2A 0c 1t’ 4) (r ‘e ta hd
SR hul ae rs e’ ) Ta rn ad
sR fe eg ru l Bat oi oo kn
ro of
t he
hL uO rD sdR a,
,C lo Ss eu pr te
o mf
t eh re i 1t 0s ,R e 2g 0i 2s 6te ,r o tf
M We em db ne er ss
aa yn ,d
S Mee ep tt ie nm gb e ar
d1 6,
e2 t0 e2 r6 m,
n( ib no gt h ed na ty is
ein mc el nu ts i ov fe ) tf ho er t mh ee
p bu er rp so se
h1 e7 "
iA nan ln u da il
iG de en ne dr a (il
declared at the AGM). Kindly display the same on your respective websites. i
SYMBOL ST ey cp ue r io tf y (BotB h o Do ak y C sl Io ns cu lr ue si ve) Record Date Purpose 1
From ‘ To
NB SS EE -- 5 K3 R1 O06 N7 O X Equity Shares SeT phu tr esd ma by, e1 0r, || SeW pe td en me bs ed ra 1y 6, , | SW ee pd tne es md bay e0, 9r , | 17" AGM 1
2026 2026 2026
4. IR ne t- ea rp nap lo Ai un dt im te on rt
o ff
M t/ hs e, yJ ea ai rm i 2n
-As 2s 7o ac si a pt ee s A,
nC eh xa urt re er Ae .d Accountants, Vadodara as
KRONOX LAB SCIENCES LIMITED i
Corporate Office Address : Block No. 284, Village : Dabhasa, Taluka : Padra, Dist. : Vadodara, Gujarat State - 391 440,
PRe hg ois nt eer e Nd o .Of f : i +ce 9 A 1d d 0r 2e 6ss 6 2: B 2lo 9c 9k 0N 0o. 2 3 53, Village : Ekalbara, Taluka : Padra, Dist. : Vadodara, Gujarat State - 391 440.
CIN : L24117GJ2008PLC055460
Email : info@kronoxlabsciences.com,
Webside : www.kronoxlabsciences.com
KRONO:;
5. Appointment of M/s. Diwanji & Associates, Cost Accountants, Vadodara as Cost
Auditors for the year 2026-27 as per Annexure -B.
The Board Meeting commenced at 02:30 P.M. and concluded at 04:30 P.M. today
This is for your information and further dissemination.
Thanking you,
Yours Faithfully
For KRONOX Lab Sciences Limited
Compahy Secretary & Compliance Officer
Membership No. A68272
KRONOX LAB SCIENCES LIMITED
Corporate Office Address : Block No. 284, Village : Dabhasa, Taluka : Padra, Dist. : Vadodara, Gujarat State - 391 440.
PRe hg ois nt eer e Nd o .Of f : i +ce 9 1Ad d 0r 2e 6ss 6 2: B 2lo 9c 9k 0No 0. 2 3 53, Village : Ekalbara, Talulea 1 Padps, Dist. : Vadodara, Gujarat State - 391 440,
CIN : L24117GJ2008PLC055460
Email ; info@kronoxlabsciences.com,
Webside : www.kronoxlabsciences.com
KRONOX LAB SCIENCES LIMITED
Regd. Office: Block No. 353, Vilage: Ekaibara, Taluka: Padra, District; Vadodara 371440 Gujaral
email: cs@kionoxlobsciences.com ; CIN: L24117GJ2008PLCO55460
Quarte Ur nl ay u & d iY le ea dr Fe in nad ne cd la F li n Ra esn uc ll ta sl fR oe rs tu hll e b Qy ua C ro lem rp a en ni de es d O 3t 0h .0e 6r . t 2h 02a 6n Banks (Rs In Lakhs)
Quarter Ended Year Ended
SN EHEtarE 30.06.202% | 31.03.2026 |_30.06.2025 | 31.03.2026
Unaudiied | Unaudiied | _Avdiied | _Audited
INCOME FROM OPERATION
1 |Revenue trom Operation 28 13 20 95 7 26 212 46 6] _ 24% 86 77 3] 101 52 12 90 4
2> |otherincome
2,968.3 2,827.3 2,516.0 10.641.4
3 Total Income
| |CE oX sP tE oN fS E MS
a terials Cunsumed
15093 11343 1.287.2) 47138
& [Changesin Inventories of Finished Goods, Work in progress (11.4) 362 (111.7) (562)
¢ o |En md p lSf oo yc ek e- i Bn en- eT fr ia td se expenses 19 33 33 164 30 4) 17 08 04 74 10 13 4
o ¢ [ |pF en pa rn ec ce i aC to is ot ns ond amortisation Expenses 34 475 .2 ¢ 325 6.9 2) 24 70 7. 51 ) 1,2 20 94 78
i |Other Expenses
1.987.3 1.730.2] 1,671.9] 6.911.1
TOTAL EXPENSES
981.0} 1,097.1 844.1 3.730.3
5 |Profit before Tax
& |Tax Expenses 2530) 2965 2184 9720]
o |cumentTox
ee dn
Ts Tae oxs
r e fl oa
t ti hn eg Pt eo rp ir oi do r years 7( 320 030 3]| 8000 0. 4 20 51 220 7.. 4 30 ), 276{70 6.. 7 00 )
8 |other Comprehensive Income.
o [ 6i f Dom e ft ih na et dw i bl e no et fi tb e P ir ae nc l la is os bi if li ie tyd / f aso s ep tr so fit or loss 140) 107, 33) 290)
il Tox impact on obove ilem 19 27) 08 73)
b [ ii ) t Eem x cth ha at n w gil el db ie f ere rc el nas cs ei f ci re id s io ng p or nof fit r onor s il ao tss i on of foreign
operaions 09) 00 09 09)
9 |Tolol Comprehensive Income for the: petlod 727.3] 808.2] 630.3] 2.787.7)
10 |Poid up shore caplial(FY Rs.10/- per shore.) 37104 374l 37104 3 77 91 00 24 3
11 O |Et ah re mr in gE q pu ei rt y e quity share (in Rupees) (F V Rs.10/- per share) 0, 22 7 7.5
(3asic & Dilluted)
Noles:
1 The above Unaudited results have been prepared in accordance with indionAccounting Standord (IND AS} nofified under
section 133 of the comparies Act, 2013, read fogelher with revelant rules issued there under ond other accounting
principles generally occepted in India.
2 The above resulls, have been reviewed by Ihs Slatulory Auditors, recommended by the Audit Committee and Approved
by ihe Board of Directors In their meeting held on 12th Augusl, 2026.
The Company s having only one reporiobie segment under Ind As-108 on “Operaling Segments” Le. manufacturing of High
3 purity Speciality Fine chemical.
The previous quarters/years figures have been regrouped/rearranged wherever necessary to moke it comparable with
4 the current quarter/year.
Date: 12/08/2026 ;J] For and on behalf of the Board of
Pioce: Vadodara KRONOX LAB SCIENCES UMITED
inbta:
Choirman & Managing Director
DIN: 02385809
MAHESH UDHWANI & ASSOCIATES
CHARTERED ACCOUNTANTS
3rd Floor, Satyam Building,
Opp. Old Vuda Office, Fatehgunj,
INDIA
Vadoda- r39a0 002, Gujarat, India
M.: +91 8758756360
Website : www.maheshudhwani.com
Independent Auditor's Review Report on the Quarterly Unaudited Standalone Financial
Results of the KRONOX LAB SCIENCES LIMITED Pursuant to the Regulation 33 of the SEBI
(Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended
Review report to
The Board of Directors
KRONOX LAB SCIENCES LIMITED
We have reviewed the accompanying statement of unaudited financial results of KRONOX LAB
SCIENCES LIMITED for the quarter ended 30" June 2026 (“the Statement”). attached herewith,
being submitted by the Company pursuant to the requirements of Regulation 33 of the SEBI
(Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (the "Listing
Regulations").
The company's Management is responsible for the preparation of the statement in accordance
with the recognition and measurement principles laid down in Indian Accounting Standard 34,
(Ind AS 34) "Interim Financial Reporting" prescribed under Section 133 of the Companies Act,
2013 as amended, read with relevant rules issued thereunder and other accounting principles
generally accepted in India and in compliance with Regulation 33 of the Listing Regulations. The
Statement has been approved by the Company's Board of Directors. Our responsibility is to
express a conclusion on the Statement based on our review.
We conducted our review of the Statement in accordance with the Standard on Review
Engagements (SRE) 2410 “Review of Interim Financial Information Performed by the
Independent Auditor of the Entity”, issued by the Institute of Chartered Accountants of India.
This standard requires that we plan and perform the review to obtain moderate
[Showing first 8,000 characters — download PDF for full document]